Concepedia

Jingsong Qiu

JQ

Statistics

Publications

4

Citations

99

H-Index

4

Active since

2022

Affiliations

Shenyang Pharmaceutical University(Current)

General Hospital of Shenyang Military Region

Tsinghua University

Jingsong Qiu is an author at Shenyang Pharmaceutical University specializing in neuroprotection, amyloid beta-targeted therapy, and brain targeting ligands.

ORCID

Publications per year

2022–2024

4

Publications

4

Design, synthesis and biological evaluation of novel coumarin derivatives as multifunctional ligands for the treatment of Alzheimer's disease

Wenjie Liu, Limeng Wu, Wenwu Liu et al. · European Journal of Medicinal Chemistry · 2022 · 46 citations · Full text

, , +16

Discovery of ZJCK-6-46: A Potent, Selective, and Orally Available Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitor for the Treatment of Alzheimer’s Disease

Huanhua Chen, Xudong Gao, Xinzhu Li et al. · Journal of Medicinal Chemistry · 2024 · 21 citations · Full text

, , +17

Discovery of novel harmine derivatives as GSK‐3β/DYRK1A dual inhibitors for Alzheimer's disease treatment

Jingsong Qiu, Xiangling Feng, Huanhua Chen et al. · Archiv der Pharmazie · 2023 · 19 citations · Full text

, , +16

Development and structure-activity relationship of tacrine derivatives as highly potent CDK2/9 inhibitors for the treatment of cancer

Limeng Wu, Wenjie Liu, Wenjie Liu et al. · European Journal of Medicinal Chemistry · 2022 · 13 citations · Full text

, , +11

1–4 of 4